Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) FCF Margin: 2020-2021

Historic FCF Margin for Cardiol Therapeutics (CRDL) over the last 2 years, with Dec 2021 value amounting to -29,904.22%.

  • Cardiol Therapeutics' FCF Margin fell 5002.00% to 12.81% in Q3 2022 from the same period last year, while for Sep 2022 it was 41.42%, marking a year-over-year change of. This contributed to the annual value of -29,904.22% for FY2021, which is 2994854.00% down from last year.
  • Per Cardiol Therapeutics' latest filing, its FCF Margin stood at -29,904.22% for FY2021, which was down 67,573.50% from 44.32% recorded in FY2020.
  • Cardiol Therapeutics' FCF Margin's 5-year high stood at 44.32% during FY2020, with a 5-year trough of -29,904.22% in FY2021.
  • Moreover, its 2-year median value for FCF Margin was -14,929.95% (2020), whereas its average is -14,929.95%.
  • Data for Cardiol Therapeutics' FCF Margin shows a maximum YoY tumbled of 2,994,854bps (in 2021) over the last 5 years.
  • Yearly analysis of 2 years shows Cardiol Therapeutics' FCF Margin stood at 44.32% in 2020, then crashed by 2,994,854bps to -29,904.22% in 2021.